F

Fluoguide AS
STO:FLUO

Watchlist Manager
Fluoguide AS
STO:FLUO
Watchlist
Price: 34.25 SEK -1.72% Market Closed
Market Cap: 466.5m SEK
Have any thoughts about
Fluoguide AS?
Write Note

Fluoguide AS
Cash Taxes Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fluoguide AS
Cash Taxes Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Taxes Paid CAGR 3Y CAGR 5Y CAGR 10Y
F
Fluoguide AS
STO:FLUO
Cash Taxes Paid
-kr5.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Cash Taxes Paid
kr991m
CAGR 3-Years
-10%
CAGR 5-Years
62%
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Cash Taxes Paid
-kr16.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Cash Taxes Paid
€6.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Cash Taxes Paid
kr12.6m
CAGR 3-Years
63%
CAGR 5-Years
27%
CAGR 10-Years
13%
Bioporto A/S
CSE:BIOPOR
Cash Taxes Paid
-kr5.5m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Fluoguide AS
Glance View

Market Cap
425m SEK
Industry
Biotechnology

FluoGuide A/S engages in the development of surgical solutions to reduce suffering for the patient and increase the likelihood of cure; as well as reducing costs for the health care system. The firm develops surgical solutions, which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system. The first product is the compound FG001, which lights up the cancer and its invasive growth into the surrounding tissue.

FLUO Intrinsic Value
38.82 SEK
Undervaluation 12%
Intrinsic Value
Price
F

See Also

What is Fluoguide AS's Cash Taxes Paid?
Cash Taxes Paid
-5.5m DKK

Based on the financial report for Dec 31, 2023, Fluoguide AS's Cash Taxes Paid amounts to -5.5m DKK.

What is Fluoguide AS's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 1Y
0%

Over the last year, the Cash Taxes Paid growth was 0%.

Back to Top